Andrew McCandlish

Andrew McCandlish is a Non-Dilutive Funding Advisor at Facile Therapeutics. Andrew has over 10 years of experience in the biopharmaceutical industry, with a focus on business development and corporate strategy. Prior to joining Facile Therapeutics, Andrew was a consultant for Meissa Vaccines, where they served as Vice President of Business Development. Andrew has also held positions at Achaogen, where they served as Director of Corporate Development, Associate Director of Corporate Development, and Manager of Alliance Management. Andrew founded Four Bases Pharma Consulting in 2010 and served as its Principal until 2011. Andrew has a Bachelor of Science in Biology from the University of California, Berkeley and a Master of Business Administration from the Anderson School of Management at the University of California, Los Angeles.

Andrew McCandlish earned a PhD in Molecular Biology from Princeton University. Andrew also holds a BS with Honors in Molecular Genetics and Business Marketing from The Ohio State University.